Advancing the Commercialization of New Cancer Innovations

National Cancer Institute SBIR & STTR: 
Advancing the Commercialization of New Cancer Innovations

The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center invites you to attend the upcoming seminar to learn about new non-dilutive funding opportunities available for early –stage companies.  The session will cover current and upcoming changes to the SBIR & STTR programs, practical strategies for developing successful proposals, and other NCI resources offered to accelerate drug development and commercialization.

Thursday, September 10 2015
10:00am-11:30am – Presentation by Ming Zhao, Ph.D., Program Director, NCI SBIR Development Center
This session will provide an overview of:
Overview of SBIR/STTR eligibility requirements.
NIH SBIR/STTR process and new cancer-focused funding opportunities from NCI
New NCI SBIR/STTR initiatives such as NIH Innovation Corps (I-Corps™) Team Training Program
NCI Investor Forum to help NCI SBIR-funded companies to connect with investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries.  
Practical strategies on how to successfully submit competitive research proposals

1:00pm – 4:30pm – One on one meetings: Opportunities for one-on-one meetings with Dr. Ming Zhao are available for attendees after the presentation.  If interested in scheduling a one-on-one meeting please complete the application prior to September 4th.  Application >
Please complete the application in Mozilla Firefox or Google Chrome browsers, do not use Internet Explorer

*NEW LOCATION*
Fitzsimons Redevelopment Authority
Bioscience Park Center
Aurora, CO 80045

Online registration is closed.  Please register onsite.

Registration complimentary for CBSA Members / $50 Non - Member

Sponsored by: